DANTROLENE SODIUM FOR INJECTION, USP

hikma canada limited🇨🇦 Health Canada

Approval Id: ebaabf9e7c0dd9f4
Drug Approval Canada Name: DANTROLENE SODIUM FOR INJECTION, USP
Product Name: DANTROLENE SODIUM FOR INJECTION, USP
Status: Marketed
Status Date: 2023-03-29
Original Market Date: 2023-03-29
Din: 02529998
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 12:20.08
Atc Original: M03CA01 DANTROLENE
Atc Name: m 03 ca 01
Aig Number: 0109855003
Company Name: hikma canada limited
Company Address: 5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9

DANTROLENE SODIUM

20 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ebaabf9e7c0dd9f4

Type

Standard